Skip to main content

Day: November 14, 2023

Nova LifeStyle, Inc. Reports Third Quarter FY 2023 Results

LOS ANGELES, Nov. 14, 2023 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced its financial results for the third quarter ended September 30, 2023. Key Financial Highlights:Operating Results for the Three Months Ended September 30, 2023Net sales for three months ended September 30, 2023 were $2.5 million, a decrease of 18% from $3.0 million in the same period of 2022. Gross profit was $1.1 million compared to $1.1 million in the same period of 2022. Net loss was ($1.3 million), compared to ($1.7 million) loss in the same period of 2022.Operating Results for the Nine Months Ended September 30, 2023Net sales for the nine months ended September 30, 2023 were $8.8 million, a decrease of 16% from $10.5 million in the same period 2022. Gross profit was $3.2 million, compared...

Continue reading

Titanium Transportation Group Reports Strong Q3 2023 Driven by Continued Growth in Trucking Segment

Demonstrates resilience amid challenging economic conditions marked by a 14% quarter over quarter revenue growth in the trucking segment reflecting revenue contribution from U.S. acquisition Completed strategic U.S. asset-based acquisition of Crane Transport (“Crane”), of Oakwood, Georgia, adding two hundred trucks, two strategically located terminals in Georgia and Alabama, and approximately US$60 million in top line annual revenue, further expanding Titanium’s North American footprint The Crane acquisition also complements Titanium’s ongoing expansion of its non-asset based logistics network, which included the opening of its seventh U.S. office in Jacksonville, Florida during the quarterBOLTON, Ontario, Nov. 14, 2023 (GLOBE NEWSWIRE) — Titanium Transportation Group Inc. (“Titanium” or the “Company”)...

Continue reading

Complete Solaria Reports Third Quarter 2023 Results

Figure 1Revenue ($M) and Gross Margin (%)Figure 2*Fab WIP (Jobs) by Work WeekFigure 3Headcount By Work Week (Down 33%)Figure 4Gross BookingsFigure 5Gross Margin Improvement by QuarterTaner OzcelikTaner OzcelikChris LundellChris LundellFREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Complete Solaria Inc. (NASDAQ: CSLR) published its third quarter 2023 results, which will be reviewed for investors at 5:00 p.m. EST today at https://investors.completesolaria.com/. Third quarter summary (financial comments based on non-GAAP results unless noted):Revenue (systems only) of $24.6 million, down 4% from previous quarter Modules sales, $3.8 million, reported as “discontinued operations,” not revenue 25% gross margin, up from 18% in the prior quarter Sale of Module business...

Continue reading

POET Technologies Reports Third Quarter 2023 Financial Results

TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today reported its unaudited consolidated financial results for the third quarter ended September 30, 2023. The Company’s financial results as well as the Management Discussion and Analysis have been filed on SEDAR+ and are available on the SEC’s EDGAR website (www.sec.gov/EDGAR). All financial figures in this press release are in United States dollars unless otherwise indicated. Business Highlights since Second Quarter Results reported on August 11, 2023:On August 9, 2023, the Company filed a registration statement...

Continue reading

Torex Gold Reports Third Quarter 2023 Results

On track to achieve production guidance with a solid start to Q4 (All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) reports the Company’s financial and operational results for the three- and nine-month periods ended September 30, 2023. Senior management of Torex will host a conference call tomorrow morning at 9:00 AM (ET) to discuss the quarterly results. Jody Kuzenko, President & CEO of Torex, stated: “We expect to close out 2023 on a solid note with the fourth quarter forecast to be the strongest quarter of production, driven by higher open pit grades now that the period of elevated waste stripping is behind us. Our confidence in achieving full year production guidance of 440,000 to 470,000 ounces (“oz”)...

Continue reading

Healthy Extracts Reports Third Quarter 2023 Results

Net Revenue up 23%, with Strong Subscription-Based Revenue Growth LAS VEGAS, Nov. 14, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported results for the three and nine months ended September 30, 2023. All comparisons are to the year-ago period unless otherwise noted. Financial & Operational HighlightsNet revenue increased 23% to $614,000 in the third quarter of 2023 and was up 27% to $1.8 million for the first nine months of 2023, driven by product line and distribution channel expansion, as well as growth in subscription-based revenue. Gross margin improved to 80.4% in the third quarter from 48.4% in the...

Continue reading

Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates

– Expanded executive team as Lourie Zak appointed Chief Financial Officer –  – Extended clinical focus on systemic administration in small cell lung cancer – – $29.9 million in cash and equivalents – WESTLAKE VILLAGE, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) —  Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third quarter of 2023 and provided general business updates. “The third quarter was highlighted by continued expansion of our executive team while advancing our pivotal Phase 3 study in platinum resistant/refractory ovarian cancer. Additionally, our small cell lung cancer trial is progressing,” said Thomas Zindrick, President, Chairman and CEO of Genelux. “Looking ahead, we remain focused on our ongoing trials, including...

Continue reading

Ashland Board appoints Sanat Chattopadhyay, executive vice president, Merck & Company, as new director effective November 13, 2023

WILMINGTON, Del., Nov. 14, 2023 (GLOBE NEWSWIRE) — Ashland Inc. (NYSE: ASH) has announced the appointment of Sanat Chattopadhyay, executive vice president of Merck & Company (NYSE: MRK) to its Board of Directors. Chattopadhyay will serve on the Board’s Environmental, Health, Safety, and Quality and Governance and Nominating Committees, effective November 13, 2023.  Prior to Merck, Chattopadhyay held leadership positions at Wyeth Pharmaceuticals, Aventis, Hoechst Marion Roussel and Hoechst India. As previously announced, Jay V. Ihlenfeld who has served as a director since 2017, and Brendan M. Cummins, who joined the board in 2012 have decided not to stand for re-election at Ashland’s Annual Stockholders Meeting in January 2024. With the addition of Chattopadhyay, Ashland temporarily increases the size of the Board to...

Continue reading

PCS Edventures! Reports Unaudited Results For the Second Quarter of Fiscal Year 2024

BOISE, Idaho, Nov. 14, 2023 (GLOBE NEWSWIRE) — PCS Edventures!, Inc. (PCSV), a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone products, today announced unaudited results of operations for its second quarter of Fiscal Year 2024 which ended on September 30, 2023. Revenue was $3.77 million, a quarterly record for the Company, up from $1.24 million in revenue for the same period last year. Net income was $1.81 million, also a quarterly record, up from $0.17 million for the same period last year. The Company ended the quarter with $2.12 million in cash. Mike Bledsoe, President, commented, “This record quarter was driven in large part by our Air Force and Iowa relationships. Excluding the revenue associated with those relationships during the quarter, our revenue would have...

Continue reading

Foreign Investment Review Board Approval Received

BRISBANE, Australia, Nov. 14, 2023 (GLOBE NEWSWIRE) — Allkem Limited (ASX: AKE, “Allkem” or the “Company”) is pleased to announce that Arcadium Lithium plc (“NewCo”), the new holding company of the combined group that will result from the proposed merger of Allkem and Livent Corporation (Livent) (Transaction), has received Australian Foreign Investment Review Board (“FIRB”) approval (“FIRB Approval”). Allkem, Livent and NewCo have now received antitrust/competition approvals in Canada, China, Japan, South Korea and the U.S., as well as foreign investment approvals/completion of investment screenings in Australia, the U.K. and the U.S. This represents all competition and foreign investment approvals that are expected to be required prior to completion1. Allkem and Livent are targeting closing of the Transaction on 4 January 2024....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.